# HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse

*PRI Rank #11 · Topics and Trends in Most Cited HIV Research and Treatment Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/hiv-research-and-treatment/2026/rank-11*

| Field | Value |
| --- | --- |
| Rank | #11 |
| 18m citations | 39 |
| Journal | JAMA |
| Year | 2024 |
| DOI | 10.1001/jama.2024.24490 |
| Corresponding authors | Kristen M Marks |
| Institution | Weill Cornell Medicine, United States |

**Ranking page:** [Topics and Trends in Most Cited HIV Research and Treatment Papers, Class of 2026](https://pri.pepkio.com/top-papers/hiv-research-and-treatment/2026)

**Paper link:** [10.1001/jama.2024.24490](https://doi.org/10.1001/jama.2024.24490)

## Topics

HepB-CpG vaccine · HepB-alum vaccine · cytosine phosphoguanine adjuvant · aluminum hydroxide adjuvant · hepatitis B vaccine nonresponse · People living with HIV (PLHIV) · seroprotection response · antibody titer against HBsAg · hepatitis B surface antigen · Antiretroviral therapy · CD4 count · HIV viral load · 2-dose vaccine regimen · 3-dose vaccine regimen · vaccine noninferiority · Intramuscular administration · hepatitis B virus immunity · revaccination strategy

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited HIV Research and Treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/hiv-research-and-treatment/2026. Accessed 2026-07-21.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```